Xifaxan 550 mg
Xifaxan 550 mg is a medicine authorised by Swissmedic under authorisation number 63216. The authorisation holder is Alfasigma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 March 2015 and the authorisation is valid without a time limit. ATC code A07AA11 places the medicine in the group Antidiarrheals, intestinal anti-inflammatory and anti-infective agents.
| Authorisation number | 63216 |
|---|---|
| Name | Xifaxan 550 mg |
| Full name | Xifaxan 550 mg, Filmtabletten |
| Authorisation holder | Alfasigma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A07AA11 |
| First authorisation | 19 March 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xifaxan 550 mg, Filmtabletten | B | 19 March 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A07AA11 | 08.01.9. | B |
| 2 | 56 | Tablette(n) | A07AA11 | 08.01.9. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Xifaxan 550 mg authorised in Switzerland?
Yes. Xifaxan 550 mg is authorised by Swissmedic under authorisation number 63216, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xifaxan 550 mg have?
Xifaxan 550 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Xifaxan 550 mg?
The authorisation holder is Alfasigma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.